Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Comment by Tropicalsunon Dec 20, 2022 8:19pm
108 Views
Post# 35183615

RE:RE:RE:longs aren't budging

RE:RE:RE:longs aren't budging
gibbonsj wrote: Tropical. With volume being what it is it's clear that few are interested in selling. What shares have been traded include a lot of head fakes to bring share price down. Whether that is short covering or patient trading really makes no difference It is very difficult in low volume situations like this to draw any conclusions but the consensus is the company is doing very well and the debentures are out of the way which improves the bottom line and the company has stayed with its calendar year guidance. That is the only reliable information we have so that's what we have to go with. The trading we see on a day-to-day basis is more often than not low volume smoke and mirrors.


gibbonsj, I agree with your post. I must admit after looking at Iscfa's recent post I am confused with these analysts revenue guidance for calender 2022 year end. Here is what we know, the latest revenue figure stated by the company is around 165 million, again they have maintained their target of between $180 and $190 million revenue run rate by the end of calendar 2022. I don't see how they get there, do you?

The charts posted have the company exiting 2022 at $149 million on the low end and $151 million on the high end, 2023 shows I believe $192 million, so what am I missing? Iscfa, please feel free to chime in this conversation. I think you used a figure of $160 million back sometime ago, so are these charts not up to date?
<< Previous
Bullboard Posts
Next >>